Skip to main content

Preparation of Lipid–Peptide–DNA (LPD) Nanoparticles and Their Use for Gene Transfection

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2118))

Abstract

Therapeutic gene delivery systems offer the potential for the treatment of a range of inherited and acquired inherited diseases. In contrast with viral gene vectors, the nonviral gene vectors provide a safer alternative and additional advantages such as the improved delivery efficiency, low cost, and often unlimited capacity to package DNA. Here we describe the preparation of a nonviral gene delivery technique based on lipid–peptide–DNA (LPD) complexes. The size of LPD particles is in the nanometer range. The use of these nanoparticulate LPDs results in high efficiency transfections and a high level of gene expression in vitro. LPDs provide a convenient and efficient tool for gene delivery in gene therapy.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Emery DE (2004) Gene therapy for genetic diseases: on the horizon. Clin Appl Immunol Rev 4:411–422

    Article  CAS  Google Scholar 

  2. Hashida M, Nishikawa M, Yamashita F, Takakura Y (2001) Cell-specific delivery of genes with glycosylated carriers. Adv Drug Deliv Rev 52:187–196

    Article  CAS  Google Scholar 

  3. Naldini L (2015) Gene therapy returns to Centre stage. Nature 526:351–360

    Article  CAS  Google Scholar 

  4. Dunbar CE, High KA, Joung JK et al (2018) Gene therapy comes of age. Science 359:4672

    Article  Google Scholar 

  5. Kay MA, Glorioso JC, Naldini L (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7:33–40

    Article  CAS  Google Scholar 

  6. Russell SJ, Peng K-W, Bell JC (2012) Oncolytic virotherapy. Nat Biotechnol 30:658–670

    Article  CAS  Google Scholar 

  7. Huang S, Kamihira M (2013) Development of hybrid viral vectors for gene therapy. Biotechnol Adv 31:208–223

    Article  CAS  Google Scholar 

  8. Yin H, Kanasty RL, Eltoukhy AA et al (2014) Non-viral vectors for gene-based therapy. Nat Rev Genet 15:541–555

    Article  CAS  Google Scholar 

  9. Wang HY, Jiang YF, Peng HG et al (2015) Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors. Adv Drug Deliv Rev 81:142–160

    Article  CAS  Google Scholar 

  10. Wang HX, Li M, Lee CM et al (2017) CRISPR/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery. Chem Rev 117:9874–9906

    Article  CAS  Google Scholar 

  11. Hardee CL, Arevalo-Soliz LM, Hornstein BD et al (2017) Advances in non-viral DNA vectors for gene therapy. Genes (Basel) 8:65

    Article  Google Scholar 

  12. Lin G, Li L, Panwar N et al (2018) Non-viral gene therapy using multifunctional nanoparticles: status, challenges, and opportunities. Coord Chem Rev 374:133–152

    Article  CAS  Google Scholar 

  13. Appaiahgari MB, Vrati S (2015) Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls. Expert Opin Biol Ther 15:337–351

    Article  CAS  Google Scholar 

  14. Jayant RD, Sosa D, Kaushik A, Atluri V et al (2016) Current status of non-viral gene therapy for CNS disorders. Expert Opin Drug Deliv 13:1433–1445

    Article  CAS  Google Scholar 

  15. Zabner J (1997) Cationic lipids used in gene transfer. Adv Drug Deliv Rev 27:17–28

    Article  CAS  Google Scholar 

  16. Zhi D, Bai Y, Yang J et al (2018) A review on cationic lipids with different linkers for gene delivery. Adv Colloid Interface Sci 253:114–140

    Article  Google Scholar 

  17. Pedroso de Lima MC, Simões S, Pires P et al (2001) Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv Drug Deliv Rev 47:277–294

    Article  CAS  Google Scholar 

  18. Morille M, Passirani C, Vonarbourg A et al (2008) Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 29:3477–3496

    Article  CAS  Google Scholar 

  19. Xiang S, Tong H, Shi Q et al (2012) Uptake mechanisms of non-viral gene delivery. J Control Release 158:371–378

    Article  CAS  Google Scholar 

  20. Remaut K, Sanders NN, Fayazpour F et al (2006) Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes. J Control Release 115:335–343

    Article  CAS  Google Scholar 

  21. Kim BK, Hwang GB, Seu YB et al (2015) DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes. BBA-Biomembranes 1848:1996–2001

    Article  CAS  Google Scholar 

  22. Zauner W, Farrow NA, Haines AM (2001) In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J Control Release 71:39–51

    Article  CAS  Google Scholar 

  23. Tsai JT, Furstoss KJ, Michnick T et al (2002) Quantitative physical characterization of lipid-polycation-DNA lipoplexes. Biotechnol Appl Biochem 36:13–20

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The manuscript was edited by Mikhail Soloviev.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hao-Ying Li .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Zhang, F., Li, HY. (2020). Preparation of Lipid–Peptide–DNA (LPD) Nanoparticles and Their Use for Gene Transfection. In: Ferrari, E., Soloviev, M. (eds) Nanoparticles in Biology and Medicine. Methods in Molecular Biology, vol 2118. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0319-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-0319-2_6

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-0318-5

  • Online ISBN: 978-1-0716-0319-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics